Drug firm Zydus Cadila on Tuesday said it has launched a generic version of anastrazole tablets used in the treatment of breast cancer, in the US market. The company has launched the drug in strength of 1 mg after getting approval from the (USFDA), Zydus Cadila said in a statement. Natco Pharma also said on Tuesday it has launched a generic version of anastrazole, used in treating breast cancer, in the US market. The product has been launched in the US through the companys marketing partners, it said, but did not name them.
Rescheduled Birla Corp AGM peaceful
The 90th annual general meeting of Birla Corporation Ltd, which was postponed and rescheduled for Tuesday, went off peacefully. The meeting had resolutions like reappointment of chairman Harsh V Lodha and adoption of annual accounts for 2009-10. The court has just directed that the ballot papers used in the polling to pass the resolutions be sealed and handed over to the CLB, Lodha said. He was talking to reporters after the annual general meeting of the company. Asked whether the company needs the Company Law Board's approval for passing resolutions, Lodha said it did not require any such approvals.
ICRA upgrades rating on IOC bonds
ICRA has upgraded the long-term rating on outstanding Rs 4,589 crore long-term bonds programme of Indian Oil Corporation (IOC) from LAA+ and positive outlook to LAAA. The upgrade in the long-term rating of IOC follows the recent decision of the government of India to grant autonomy to the PSU oil marketing companies to revise petrol prices, and possible autonomy in revising diesel prices in the near term. The rating upgrade also considers price hikes announced by the government on four sensitive petroleum products petrol, diesel, LPG (domestic) and SKO (PDS), which will reduce the gross under recovery burden for the PSU OMCs and improve their liquidity position, a media release said.
Emtelle Holdings in tie-up with Parixit
Dutch company Emtelle Holdings on Tuesday said its has entered into a strategic alliance with Parixit Industries (India) to provide turnkey solutions to the telecom, power and infrastructure sectors. Under the alliance, the two partners would manufacture and market a comprehensive range of micro irrigation systems, PE pressure pipes and ducted network solutions in the Indian and overseas markets, a press release said.
Amway sets ambitious target
Amway plans to become a Rs 2,500-crore company by 2012 turning its focus on eastern India. Launching a new office, vice-president (East) Diptarag Bhattacharjee, said the company has set 22% growth target for 2010.